AUTHORS
Ramya Balasubramanian, BS, Alexandria Vangelatos, BA2, Casey MacVeagh3, Gabrielle Lapping-Carr, MD4, Nabil Abou Baker, MD5, Austin Wesevich, MD, MPH, MS6
AFFILIATIONS
1 University of Chicago, Chicago, United States
2 Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, United States
3 Carleton College, Northfield, United States
4 University of Chicago, Chicago, United States
5 University of Chicago, Chicago, United States
6 Ohio State University, Columbus, Ohio, United States
ABSTRACT
Introduction:
Vaso-occlusive episodes (VOEs) are the leading cause of emergency department (ED) visits and hospitalization among adults with sickle cell disease (SCD), and they require rapid, effective pain control. The American Society of Hematology (ASH) and the National Heart, Lung, and Blood Institute (NHLBI) recommend initiation of analgesia within 60 minutes of presentation with VOE. Unfortunately, ED-based care only meets these guidelines 14% of the time, with prior studies reporting 70 to 190 minutes to first opioid for patients with SCD. While alternative ambulatory care settings such as infusion centers and day hospitals have improved the timeliness of analgesia, presentation to specialty outpatient or transition care clinics has not been similarly studied. It is also unclear how timeliness of subsequent inpatient admission may be impacted by the initial location of presentation. We evaluated associations between initial presentation setting and key drivers of VOE care quality: opioid timeliness, guideline concordance, and admission timeliness.
Methods:
We conducted a retrospective cohort study of adults with SCD hospitalized for VOE at the University of Chicago between January 1 and August 4, 2023. Hospitalizations were stratified by initial presentation setting: ED, transition urgent care (a dedicated pathway for rapid pain management), or hematology clinic - all on the University of Chicago campus. Outcomes included time to first opioid administration, opioid administration within 1 hour (guideline concordance), time to inpatient admission, and provision of a same-day appointment if presenting to transition urgent care or hematology clinic with VOE. Multivariable, multilevel linear and logistic models clustered hospitalizations within patients and adjusted for age, sex, neighborhood vulnerability (Social Vulnerability Index) sample quartile, and inpatient healthcare utilization in the prior year (number of hospitalizations in 2022). Sensitivity analyses were restricted to presentations during business hours (non-holiday weekdays from 8 AM to 5 PM) and to hospitalizations without crossover between settings prior to admission.
Results:
Of the 401 hospitalizations across 149 patients, 322 (80%) initially presented to the ED, 46 (11%) to transition urgent care, and 33 (8%) to hematology clinic. Sociodemographic and clinical factors did not significantly differ by initial presentation setting. When patients presented to transition urgent care or hematology clinic, they did so through a same-day appointment 85% and 58% of the time, respectively. Median time to first opioid was 2.3 hours in the ED, 0.5 hours in transition urgent care, and 0.4 hours in hematology clinic (p<0.001). After adjusting for sociodemographic and clinical factors, opioid administration was 2.5 hours faster (95% CI 1.7-3.2) for transition urgent care presentations and 1.9 hours faster (95% CI 1.0-2.8) for hematology clinic presentations compared with the ED. Opioid timeliness guideline concordance was 14% in the ED, 89% in transition urgent care, and 73% in hematology clinic (p<0.001). Of note, patients in the highest neighborhood vulnerability quartile had lower odds of guideline-concordant opioid administration than those in the least vulnerable quartile (aOR 0.27, 95% CI 0.09-0.80). In the adjusted model, time to admission was 7.5 hours faster (95% CI 5.4-9.5) when presenting to transition urgent care and 5.1 hours faster (95% CI 2.7-7.5) when presenting to hematology clinic compared with the ED. In the sensitivity analyses, both transition urgent care and hematology clinic presentations had significantly faster admission timeliness than the ED after restricting to the 368 hospitalizations without crossover between settings (92%) and when restricting to the 191 presentations during business hours (48%).
Conclusions:
Among adults with SCD hospitalized for VOE, presentation to transition urgent care or hematology clinic was associated with substantially faster opioid administration, higher guideline concordance, and shorter time to admission than presentation to the ED. Our academic center’s experience suggests that expanding ambulatory, SCD-specific care pathways can improve care timeliness for adults with SCD presenting with acute pain. Given disparities in opioid timeliness guideline concordance by neighborhood vulnerability, additional interventions are needed to mitigate health disparities across this vulnerable patient population.
DISCLOSURES
Ramya Balasubramanian, BS: No relevant conflicts of interest to declare.